Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance Find Stocks Now
Close

EXACT Sciences Corporation (EXAS)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow EXACT Sciences's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
63.24 -0.29    -0.46%
24/04 - Closed. Currency in USD ( Disclaimer )
Pre Market
64.00
+0.76
+1.20%
7:29:13 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 1,175,718
  • Bid/Ask: 60.01 / 66.00
  • Day's Range: 63.22 - 64.28
EXACT Sciences 63.24 -0.29 -0.46%

EXAS Balance Sheet

 
Featured here, the Balance Sheet for EXACT Sciences Corporation, which summarizes the company's financial position including assets, liabilities and shareholder equity for each of the latest 4 period ending dates (either quarterly or annually).
AnnualQuarterly
InvestingPro Advanced Balance Sheet
Period Ending: 2023
31/12
2023
30/09
2023
30/06
2023
31/03
Total Current Assets 1194.37 1148.19 1173.93 1091.38
Cash and Short Term Investments 777.64 734.41 775.71 698.65
Cash - - - -
Cash & Equivalents 605.38 594.61 604.36 421.36
Short Term Investments 172.27 139.79 171.35 277.28
Total Receivables, Net 207.42 203.2 182.12 187.17
Accounts Receivables - Trade, Net 203.62 199.4 178.32 183.37
Total Inventory 127.48 132.84 130.77 124.09
Prepaid Expenses 81.83 77.44 85.03 81.18
Other Current Assets, Total - 0.297 0.297 0.297
Total Assets 6471.33 6420.83 6355.56 6304.33
Property/Plant/Equipment, Total - Net 853.36 833.58 833.79 840.76
Property/Plant/Equipment, Total - Gross 1270.56 1221.91 1193.96 1174.92
Accumulated Depreciation, Total -417.2 -388.34 -360.16 -334.16
Goodwill, Net 2367.12 2366.51 2346.25 2346.24
Intangibles, Net 1890.4 1913.31 1910.56 1933.48
Long Term Investments 51.17 36.8 39.3 43.6
Note Receivable - Long Term 3.8 3.8 3.8 3.8
Other Long Term Assets, Total 73.22 33.05 39.34 38.77
Other Assets, Total 134.02 159.13 132.7 224.6
Total Current Liabilities 514.7 476.51 488.06 367.35
Accounts Payable 78.82 73.56 75.08 86.71
Payable/Accrued - - - -
Accrued Expenses 324.52 309.87 299.59 241.84
Notes Payable/Short Term Debt - - - -
Current Port. of LT Debt/Capital Leases 83.78 84.69 83.67 33.21
Other Current liabilities, Total 27.59 8.39 29.72 5.58
Total Liabilities 3326.03 3299.6 3298.94 3246.62
Total Long Term Debt 2321.78 2321.32 2319.27 2367
Long Term Debt 2314.28 2312.92 2311.57 2360.2
Capital Lease Obligations 7.5 8.4 7.7 6.8
Deferred Income Tax 17.3 18.7 19.8 20.1
Minority Interest - - - -
Other Liabilities, Total 472.25 483.07 471.82 492.17
Total Equity 3145.3 3121.23 3056.62 3057.71
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total 1.82 1.81 1.81 1.8
Additional Paid-In Capital 6611.24 6540.36 6475.74 6396.8
Retained Earnings (Accumulated Deficit) -3469.18 -3419.41 -3420.2 -3339.18
Treasury Stock - Common - - - -
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total 1.43 -1.54 -0.723 -1.72
Total Liabilities & Shareholders' Equity 6471.33 6420.83 6355.56 6304.33
Total Common Shares Outstanding 181.36 180.81 180.55 179.83
Total Preferred Shares Outstanding - - - -
* In Millions of USD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

EXAS Comments

Write your thoughts about EXACT Sciences Corporation
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Dixon Kwok
Dixon Kwok Apr 09, 2023 9:53PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
wow
Денис Кондраков
Денис Кондраков Nov 01, 2021 11:45AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
120 go now
Mary Miller
Mary Miller Jul 28, 2021 4:13PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
For everyone that decided to hold EXAS over night look at the after hours price.
Sccoott Mmaarrt
Sccoott Mmaarrt Jun 24, 2021 8:48PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
The future is now
Michael Stassen
Michael Stassen Feb 25, 2021 8:14AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Its about the future of medicine
Official Dummy
OfficialDummy Dec 29, 2020 12:00PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
shiotcoin
Ell Skware
Ell Skware Sep 24, 2020 12:04PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Congratulations on a good pick ;)
MoneyManager MoneyManager
Money2Manage4U Sep 24, 2020 12:04PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
they took approval from FDA ?
andrew mccorkle
andrew mccorkle Apr 23, 2020 8:12PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Ohio
Wojciech Stefaniak
Wojciech Stefaniak Jan 17, 2020 3:06PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Lesson 1: don't follow worthless "guru" recommendations! Otherwise you lost your money.
Rita Brattkus
Rita Brattkus Nov 08, 2019 9:23AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Bottom! on it's way up...
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email